Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9334 | 1165 | 47.9 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
747 | 2 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//MDR1 | 12474 |
9334 | 1 | ABCG2//BCRP//BREAST CANCER RESISTANCE PROTEIN | 1165 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ABCG2 | authKW | 3081911 | 22% | 47% | 252 |
2 | BCRP | authKW | 1625334 | 12% | 43% | 145 |
3 | BREAST CANCER RESISTANCE PROTEIN | authKW | 574934 | 6% | 32% | 69 |
4 | ABCG2 BCRP | authKW | 337897 | 2% | 68% | 19 |
5 | BCRP ABCG2 | authKW | 188695 | 1% | 60% | 12 |
6 | MULTIDRUG RESISTANCE | authKW | 177400 | 17% | 3% | 199 |
7 | MEMBRANE GRP | address | 176870 | 2% | 25% | 27 |
8 | BREAST CANCER RESISTANCE PROTEIN BCRP | authKW | 143811 | 1% | 37% | 15 |
9 | ABC TRANSPORTER | authKW | 137954 | 7% | 6% | 84 |
10 | DESARROLLO GANADERO SANIDAD ANIM INDEGSAL | address | 134787 | 1% | 86% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 4372 | 33% | 0% | 379 |
2 | Pharmacology & Pharmacy | 4083 | 35% | 0% | 413 |
3 | Chemistry, Medicinal | 436 | 6% | 0% | 75 |
4 | Biochemistry & Molecular Biology | 304 | 18% | 0% | 204 |
5 | Hematology | 238 | 5% | 0% | 60 |
6 | Biophysics | 127 | 5% | 0% | 57 |
7 | Cell Biology | 122 | 7% | 0% | 85 |
8 | Medicine, Research & Experimental | 94 | 5% | 0% | 53 |
9 | Toxicology | 40 | 3% | 0% | 30 |
10 | Cell & Tissue Engineering | 36 | 1% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MEMBRANE GRP | 176870 | 2% | 25% | 27 |
2 | DESARROLLO GANADERO SANIDAD ANIM INDEGSAL | 134787 | 1% | 86% | 6 |
3 | CIENCIAS BIOMED FISIOL | 93601 | 0% | 71% | 5 |
4 | EXPT THER Y | 88839 | 4% | 8% | 43 |
5 | BRAIN BARRIERS | 84532 | 1% | 32% | 10 |
6 | CANC THER EUT BRANCH | 78790 | 2% | 15% | 20 |
7 | DESARROLLO GANADERO SANIDAD ANIM | 69888 | 0% | 67% | 4 |
8 | BIOMED SCI PHYSIOL | 64703 | 1% | 22% | 11 |
9 | BALTIMORE VET MED | 58969 | 0% | 75% | 3 |
10 | EQUIPE BIOINFORMAT STRUCT INTERACT | 58969 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND DISPOSITION | 11286 | 5% | 1% | 57 |
2 | MOLECULAR CANCER THERAPEUTICS | 5378 | 2% | 1% | 29 |
3 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 4098 | 1% | 1% | 14 |
4 | MOLECULAR PHARMACEUTICS | 2975 | 2% | 1% | 19 |
5 | CANCER RESEARCH | 1745 | 4% | 0% | 52 |
6 | CHINESE JOURNAL OF CANCER | 1649 | 0% | 1% | 5 |
7 | MOLECULAR PHARMACOLOGY | 1640 | 2% | 0% | 25 |
8 | PHARMACEUTICAL RESEARCH | 1411 | 2% | 0% | 21 |
9 | BIOCHEMICAL PHARMACOLOGY | 1316 | 3% | 0% | 31 |
10 | SLAS DISCOVERY | 1246 | 0% | 5% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ABCG2 | 3081911 | 22% | 47% | 252 | Search ABCG2 | Search ABCG2 |
2 | BCRP | 1625334 | 12% | 43% | 145 | Search BCRP | Search BCRP |
3 | BREAST CANCER RESISTANCE PROTEIN | 574934 | 6% | 32% | 69 | Search BREAST+CANCER+RESISTANCE+PROTEIN | Search BREAST+CANCER+RESISTANCE+PROTEIN |
4 | ABCG2 BCRP | 337897 | 2% | 68% | 19 | Search ABCG2+BCRP | Search ABCG2+BCRP |
5 | BCRP ABCG2 | 188695 | 1% | 60% | 12 | Search BCRP+ABCG2 | Search BCRP+ABCG2 |
6 | MULTIDRUG RESISTANCE | 177400 | 17% | 3% | 199 | Search MULTIDRUG+RESISTANCE | Search MULTIDRUG+RESISTANCE |
7 | BREAST CANCER RESISTANCE PROTEIN BCRP | 143811 | 1% | 37% | 15 | Search BREAST+CANCER+RESISTANCE+PROTEIN+BCRP | Search BREAST+CANCER+RESISTANCE+PROTEIN+BCRP |
8 | ABC TRANSPORTER | 137954 | 7% | 6% | 84 | Search ABC+TRANSPORTER | Search ABC+TRANSPORTER |
9 | ABC TRANSPORTERS | 109283 | 5% | 7% | 59 | Search ABC+TRANSPORTERS | Search ABC+TRANSPORTERS |
10 | BCRP INHIBITOR | 109203 | 0% | 83% | 5 | Search BCRP+INHIBITOR | Search BCRP+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MAO, QC , UNADKAT, JD , (2015) ROLE OF THE BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2) IN DRUG TRANSPORT-AN UPDATE.AAPS JOURNAL. VOL. 17. ISSUE 1. P. 65 -82 | 126 | 65% | 40 |
2 | NAKANISHI, T , ROSS, DD , (2012) BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2): ITS ROLE IN MULTIDRUG RESISTANCE AND REGULATION OF ITS GENE EXPRESSION.CHINESE JOURNAL OF CANCER. VOL. 31. ISSUE 2. P. 73-99 | 161 | 67% | 64 |
3 | NATARAJAN, K , XIE, Y , BAER, MR , ROSS, DD , (2012) ROLE OF BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2) IN CANCER DRUG RESISTANCE.BIOCHEMICAL PHARMACOLOGY. VOL. 83. ISSUE 8. P. 1084 -1103 | 148 | 58% | 135 |
4 | JANI, M , AMBRUS, C , MAGNAN, R , JAKAB, KT , BEERY, E , ZOLNERCIKS, JK , KRAJCSI, P , (2014) STRUCTURE AND FUNCTION OF BCRP, A BROAD SPECIFICITY TRANSPORTER OF XENOBIOTICS AND ENDOBIOTICS.ARCHIVES OF TOXICOLOGY. VOL. 88. ISSUE 6. P. 1205 -1248 | 210 | 47% | 12 |
5 | NI, ZL , BIKADI, Z , ROSENBERG, MF , MAO, QC , (2010) STRUCTURE AND FUNCTION OF THE HUMAN BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2).CURRENT DRUG METABOLISM. VOL. 11. ISSUE 7. P. 603-617 | 110 | 83% | 103 |
6 | POLGAR, O , ROBEY, RW , BARES, SE , (2008) ABCG2: STRUCTURE, FUNCTION AND ROLE IN DRUG RESPONSE.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 4. ISSUE 1. P. 1-15 | 129 | 76% | 107 |
7 | ROBEY, RW , IERANO, C , ZHAN, ZR , BATES, SE , (2011) THE CHALLENGE OF EXPLOITING ABCG2 IN THE CLINIC.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 12. ISSUE 4. P. 595 -608 | 131 | 74% | 32 |
8 | ROBEY, RW , POLGAR, O , DEEKEN, J , TO, KW , BATES, SE , (2007) ABCG2: DETERMINING ITS RELEVANCE IN CLINICAL DRUG RESISTANCE.CANCER AND METASTASIS REVIEWS. VOL. 26. ISSUE 1. P. 39-57 | 132 | 66% | 191 |
9 | STACY, AE , JANSSON, PJ , RICHARDSON, DR , (2013) MOLECULAR PHARMACOLOGY OF ABCG2 AND ITS ROLE IN CHEMORESISTANCE.MOLECULAR PHARMACOLOGY. VOL. 84. ISSUE 5. P. 655-669 | 114 | 69% | 50 |
10 | MAO, QC , UNADKAT, JD , (2005) ROLE OF THE BREAST CANCER RESISTANCE PROTEIN (ABCG2) IN DRUG TRANSPORT.AAPS JOURNAL. VOL. 7. ISSUE 1. P. E118-E133 | 112 | 81% | 209 |
Classes with closest relation at Level 1 |